Weight Loss vs. A1C for Type 2 Diabetes Control
DiabetesType 2 Diabetes

Weight Loss vs. A1C: Which Is Key for Managing Type 2 Diabetes?

Weight Loss vs. A1C: Which Is Key for Managing Type 2 Diabetes?
Everyday Health
By
Published on April 17, 2026
by

For those with type 2 diabetes (T2D), testing A1C levels has long been considered the gold standard of diabetes management. But it only measures the symptoms of type 2 diabetes. Weight loss, on the other hand, provides a tangible way to reduce underlying factors of the disease.

If you are overweight, meaning your body mass index (BMI) is 25 or higher, you may benefit from losing 10 to 15 percent of your body weight rather than focusing on A1C tests alone to reach remission.

Next up video playing in 10 seconds

7 Ways to Finally Hit Your A1C Target

Discover 7 strategic habits to help you finally reach your A1C goals.
Read More

The Traditional Approach: Why A1C Matters

An A1C test measures the average amount of sugar (glucose) in your blood in the past three months, reported as a percentage. Tracking it helps you and your doctor evaluate your diabetes management plan and determine if you need to make any changes.

Treatment guidelines for T2D currently recommend A1C tests at an initial assessment, every three months after that, and then twice per year once blood sugar goals have been reached and maintained.

“A1C is still a very important marker because it tells us how much glucose has been circulating in the blood,” says Nuzhat Chalisa, MD, the director of the endocrinology, diabetes, and obesity clinic at Morris Hospital and Healthcare Center in Channahon, Illinois, and a member of the Obesity Medicine Association's Communications Committee. “However, A1C alone does not explain why the glucose is high. If we focus only on A1C, we may control glucose numbers without fully addressing the pathology behind the disease,” she says.

Also, the usefulness of A1C is limited in that it’s an average over several months. Increasingly, continuous glucose monitoring is being recommended because it provides more nuanced information on how your blood sugar responds to meals, physical activity, and medication changes — factors that A1C can’t track.

How Weight Loss Drives Remission

Research shows that a 10 to 15 percent reduction in body weight can lead to T2D remission in most people with recently diagnosed disease.

 “We have now recognized that meaningful weight loss can do more than just improve glucose numbers,” Dr. Chalisa says. “In some people, it can actually modify the course of disease.”
Excess fat in three key places — the liver, pancreas, and around abdominal organs — is associated with T2D.

Visceral fat (found around your organs) is an important source of inflammatory molecules, which drives the development of insulin resistance and diabetes.

Too much fat in your liver can contribute to the accumulation of fat in your pancreas, which disrupts beta cells (insulin-producing cells) and impairs insulin production. Removing that excess fat through weight loss can allow the beta cell function to recover if it’s done soon enough — which underscores why early intervention is important.

That doesn’t just apply if you’re overweight. One small study of 20 participants with an average BMI of 25 (on the threshold of “normal” and “overweight”) found that 70 percent achieved T2D remission by going on a structured, low-calorie diet program and losing about 10 percent of their body weight.

Researchers attribute that to a reduction in liver and pancreas fat. But it’s important to note that it can be unhealthy to try to lose weight if your weight is considered normal, and you definitely should not do so if you’re already underweight. Your doctor can advise you on how your specific weight relates to your diabetes.

The Role of GLP-1s

GLP-1s (glucagon-like peptide-1 receptor agonists) help you lose weight by suppressing appetite, enhancing how full you feel, and slowing down the speed at which your stomach empties. They also regulate metabolic processes such as insulin secretion from the pancreas, which helps stabilize blood glucose levels — bridging the gap between glucose control and weight loss.

Your doctor may recommend a GLP-1 if you haven’t reached your A1C target after three months of taking the standard type 2 diabetes medication metformin, and you have additional conditions like heart failure or chronic kidney disease.

But this type of medication may be prescribed even if you don’t fit this criteria.

“Patients do not need to fail older medications first before asking about therapies that target both glucose and weight,” Chalisa says.

The sooner you get your diabetes under control, the lower your chances of complications like cardiovascular disease, kidney disease, vision problems, and nerve damage.

“If we can address this very early, even in the prediabetic phase, we are significantly increasing the quality and duration of life,” says Pouya Shafipour, MD, a board-certified family and obesity medicine physician at Providence Saint John’s Health Center in Santa Monica, California.

Shifting Your Mindset: From Management to Remission

Certain factors like genetics, medical conditions, medications, supplements, and even lab errors can affect the accuracy of A1C tests.

 Fluctuating test results can lead you to feel discouraged or as though you’re failing even when you’re making progress, Chalisa says.

“For many patients, a weight goal feels more concrete, and easier to track over time than glucose values,” she says. “A realistic weight target can create a stronger sense of momentum and control.”

And weight loss also has many other health benefits beyond diabetes control.

“Having overweight or obesity can be a big psychological issue in terms of self-confidence, socialization, and how you feel about yourself,” Dr. Shafipour says. “With patients, I try to focus on the why behind the weight loss — which really adds a lot of inspiration and power to the weight loss and reduces failure.”

The Takeaway

  • Focusing on weight loss is an effective and tangible way to control type 2 diabetes.
  • A1C is still an important marker of how much glucose has been circulating in your blood, but it doesn’t address underlying factors like excess fat in the liver, pancreas, and abdominal organs.
  • GLP-1s may be a good option for those who haven’t reached their A1C targets with metformin, since these newer drugs help with both glucose control and weight loss.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Noronha JC et al. Total Diet Replacement Within an Integrated Intensive Lifestyle Intervention for Remission of Type 2 Diabetes: Lessons From DiRECT. Frontiers in Endocrinology. June 1, 2022.
  2. A1C. Cleveland Clinic. November 22, 2022.
  3. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes – 2025. Diabetes Care. January 2025.
  4. Yamazaki H et al. Fat Distribution Patterns and Future Type 2 Diabetes. Diabetes. June 20, 2022.
  5. Bensussen A et al. Molecular Tracking of Insulin Resistance and Inflammation Development on Visceral Adipose Tissue. Frontiers in Immunology. March 21, 2023.
  6. Trenell M et al. Nutrition Interventions for Remission of Type 2 Diabetes: Potential Role for Diabetes-Specific Nutrition Formulas. Clinical Diabetes. October 28, 2024.
  7. Taylor R et al. 218-LB: Remission of Type 2 Diabetes after Weight Loss in "Normal" Weight People—The ReTUNE Study. Diabetes. June 1, 2022.
  8. Type 2 Diabetes Remission for People of a Healthy Weight. Diabetes UK. January 29, 2024.
  9. Moiz A et al. Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation. The American Journal of Medicine. June 2025.
  10. GLP-1 Agonists. Cleveland Clinic. July 3, 2023.
  11. Understanding Diabetes: The Importance of Early Detection and Management. UChicago Medicine. October 27, 2024.
Meet Our Experts
See Our Editorial PolicyMeet Our Health Expert Network
Reyna-Franco-bio

Reyna Franco, RDN

Medical Reviewer
Member of American College of Lifestyle Medicine

Reyna Franco, RDN, is a New York City–based dietitian-nutritionist, certified specialist in sports dietetics, and certified personal trainer. She is a diplomate of the American Col...

See full bio

Kelsey Kloss

Author

Kelsey Kloss is a health and wellness journalist with over a decade of experience. She started her career as an in-house editor for brands including Reader’s Digest, Elle Decor, Go...

See full bio
See Our Editorial PolicyMeet Our Health Expert Network